Bone Biologics Corporation (BBLG)
BBLG Stock Price Chart
Explore Bone Biologics Corporation interactive price chart. Choose custom timeframes to analyze BBLG price movements and trends.
BBLG Company Profile
Discover essential business fundamentals and corporate details for Bone Biologics Corporation (BBLG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
13 Oct 2021
Employees
2.00
Website
https://www.bonebiologics.comCEO
Jeffrey Frelick
Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
BBLG Financial Timeline
Browse a chronological timeline of Bone Biologics Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$1.23.
Earnings released on 14 Aug 2025
EPS came in at -$1.33 falling short of the estimated -$0.58 by -129.31%.
Stock split effective on 10 Jun 2025
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 May 2025
EPS came in at -$1.92 falling short of the estimated -$0.48 by -300.00%.
Earnings released on 5 Mar 2025
EPS came in at -$0.61 surpassing the estimated -$0.65 by +6.15%.
Earnings released on 14 Nov 2024
EPS came in at -$14.22 falling short of the estimated -$3.60 by -295.00%.
Earnings released on 9 Aug 2024
EPS came in at -$4.02 surpassing the estimated -$8.34 by +51.80%.
Earnings released on 14 May 2024
EPS came in at -$7.86 surpassing the estimated -$45.59 by +82.76%.
Earnings released on 4 Apr 2024
EPS came in at -$2.47 surpassing the estimated -$5.60 by +55.89%.
Stock split effective on 20 Dec 2023
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2023
EPS came in at -$29.27 surpassing the estimated -$145.89 by +79.94%.
Earnings released on 14 Aug 2023
EPS came in at -$81.10 falling short of the estimated -$71.99 by -12.65%.
Stock split effective on 7 Jun 2023
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2023
EPS came in at -$331.47 surpassing the estimated -$2.16K by +84.67%.
Earnings released on 30 Mar 2023
EPS came in at $144.12 surpassing the estimated -$0.22 by +65.61K%.
Earnings released on 14 Nov 2022
EPS came in at -$172.94 surpassing the estimated -$360.29 by +52.00%.
Earnings released on 11 Aug 2022
EPS came in at -$72.06 surpassing the estimated -$172.94 by +58.33%.
Earnings released on 13 May 2022
EPS came in at -$100.88 surpassing the estimated -$288.23 by +65.00%.
Earnings released on 15 Mar 2022
EPS came in at -$4.13 falling short of the estimated -$0.17 by -2.33K%.
Earnings released on 16 Nov 2021
EPS came in at -$9.95 .
Stock split effective on 13 Oct 2021
Shares were split 1 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 Aug 2021
EPS came in at -$9.62 .
Earnings released on 21 May 2021
EPS came in at -$35.61 .
Earnings released on 15 Apr 2021
EPS came in at -$8.88 .
Earnings released on 15 Apr 2021
EPS came in at -$7.71 .
Earnings released on 15 Apr 2021
EPS came in at -$7.43 .
Earnings released on 15 Apr 2021
EPS came in at -$11.67 .
Stock split effective on 2 Nov 2020
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
BBLG Stock Performance
Access detailed BBLG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.